E24. Low-dose intrauterine levonorgestrel release protects the endometrium during estrogen replacement: An update

European Journal of Cancer, Supplement

Volumn 2, Issue 9 SPEC. ISS., 2004, Pages 70-71

  Wildemeersch, D ^a   Weyers, S ^b   Janssens, D ^b,c   Schacht, E ^b,c  

^a Department of Obstetrics   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Gynecologische Dienst   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL DERIVATIVE; ESTROGEN; LEVONORGESTREL;

CANCER PREVENTION; CONFERENCE PAPER; DRUG RELEASE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 9744219797     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2004.08.025     Document Type: Conference Paper

References (9)

1. Wildemeersch D, Schacht E, Wildemeersch P. Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri- and post-menopausal women. Maturitas 2002, 44, 237-245.
2. Wildemeersch D, Dhont M. Treatment of non atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system. Am J Obstet Gynecol 2003, 138, 1297-1298.
3. Fleischer AC, Kalemeris GC, Machin JE, Entman SS, James AE. Sonographic depiction of normal and abnormal endometrium with histopathologic correlation. J Ultrasound Med 1986, 5, 445-452.
4. Hendrickson MR, Kempson RL. Surgical pathology of the uterine corpus. In: Major problems in Pathology. Vol. 12 Saunders WB. ISBN 0-7216-4644-1. 1980. p. 99-158.
5. Riphagen FE. Intrauterine application of progestins in hormone replacement therapy: a review. Climacteric 2000, 3, 199-211.
6. Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986, 5, 235-241.
7. Beresford SA, Weiss NS, Voight LF, McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestogen therapy in postmenopausal women. Lancet 197, 349, 458-461.
8. Whitehead MI, Townsond PT, Pryse-Davies J, Ryder TA, King RJB. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. New Engl J Med 1981, 305, 1599-1605.
9. Goldstein SR. Endometrial safety during hormone replacement therapy: comparison of transvaginal sonography and endometrial biopsy. Menopause 1998, 5, 132-133.